Therapy News and Research

RSS

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

7 Aug 2017

Compound derived from cannabis may alter blood levels of antiepileptic drugs

New research published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggests that an investigational neurological treatment derived from cannabis may alter the blood levels of commonly used antiepileptic drugs.

7 Aug 2017

HIV prevention and treatment being overlooked in older populations

When it comes to HIV prevention and treatment, there is a growing population that is being overlooked -- older adults -- and implicit ageism is partially responsible for this neglect, according to a presentation at the 125th Annual Convention of the American Psychological Association.

4 Aug 2017

Scientists creating blood test to identify breast cancer patients at risk for brain metastasis

Houston Methodist cancer researchers are now closer to creating a blood test that can identify breast cancer patients who are at increased risk for developing brain metastasis, and also monitor disease progression and response to therapy in real time.

4 Aug 2017

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.

4 Aug 2017

Researchers explore why physicians underprescribe drug approved to treat opioid addiction

A drug approved for private physicians to treat opioid addiction is being underprescribed, and a survey of addiction specialists suggests that many of them are not willing to increase their use of it, despite an expanding opioid addiction epidemic in the United States, according to research presented at the 125th Annual Convention of the American Psychological Association.

4 Aug 2017

Rush Midlife Center addresses health needs of women going through perimenopause

Rush has launched an innovative program dedicated to the comprehensive care of women 40 years of age and older.

4 Aug 2017

University of Rhode Island professor leads team expanding clinical practice guidelines for neck pain

A professor at the University of Rhode Island led an international team of experts who spent several years revising and expanding clinical practice guidelines for the treatment of neck pain.

3 Aug 2017

Experimental drug protects mice from obesity-related liver disease

A drug developed at the University of Rochester Medical Center protected mice from one of the many ills of our cheeseburger and milkshake-laden Western diet -- non-alcoholic fatty liver disease.

3 Aug 2017

Yoga appears to lessen symptoms of depression

People who suffer from depression may want to look to yoga as a complement to traditional therapies as the practice appears to lessen symptoms of the disorder, according to studies presented at the 125th Annual Convention of the American Psychological Association.

3 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

Gene-therapy administered through skin transplants could enable treatment of many diseases

A research team based at the University of Chicago has overcome challenges that have limited gene therapy and demonstrated how their novel approach with skin transplantation could enable a wide range of gene-based therapies to treat many human diseases.

3 Aug 2017

Researchers reveal potential of radiomics to improve precision medicine

Precision medicine has become the leading innovation of cancer treatment. Patients are routinely treated with drugs that are designed to target specific tumors and molecules.

3 Aug 2017

Genetic testing benefits youngest epilepsy patients, study finds

Because of genetic testing, Orion Maynard's parents knew the cause of his epilepsy weeks after he was born.

3 Aug 2017

Scientists propose therapeutic strategy to suppress formation of hereditary bony tumors

Patients with multiple hereditary exostoses (MHE)--a rare disease that causes the growth of multiple benign bone tumors -- have limited treatment options.

3 Aug 2017

Loyola participating in landmark study to examine use of PET scans to detect Alzheimer’s disease

Loyola Medicine is participating in a landmark $100 million study of the effectiveness of using PET scans to detect Alzheimer's disease.

3 Aug 2017

Researchers develop potential stem cell treatment for several lung conditions

A team of scientists from the UNC School of Medicine and North Carolina State University has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis -- often-fatal conditions that affect tens of millions of Americans.

3 Aug 2017

Injectable ART may have same effectiveness as standard oral treatments

Antiretroviral therapy (ART) intramuscularly administered may have the same effectiveness as current oral treatments.

3 Aug 2017

Statins prescribed to less than 50% of stroke patients across the US, says study

A new research published in the Open Access Journal of the American Heart Association/American Stroke Association - Journal of the American Heart Association - suggests that, prescriptions for statins, a type of cholesterol-lowering medication, are received by less than a half of the stroke patients discharged from the hospital across the nation.

3 Aug 2017

Therapy News and Research

Tackling food allergies: is immunotherapy the answer?

Compound derived from cannabis may alter blood levels of antiepileptic drugs

HIV prevention and treatment being overlooked in older populations

Scientists creating blood test to identify breast cancer patients at risk for brain metastasis

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Researchers explore why physicians underprescribe drug approved to treat opioid addiction

Rush Midlife Center addresses health needs of women going through perimenopause

University of Rhode Island professor leads team expanding clinical practice guidelines for neck pain

Experimental drug protects mice from obesity-related liver disease

Yoga appears to lessen symptoms of depression

FDA approves new treatment for all HCV genotypes 1-6

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

Gene-therapy administered through skin transplants could enable treatment of many diseases

Researchers reveal potential of radiomics to improve precision medicine

Genetic testing benefits youngest epilepsy patients, study finds

Scientists propose therapeutic strategy to suppress formation of hereditary bony tumors

Loyola participating in landmark study to examine use of PET scans to detect Alzheimer’s disease

Researchers develop potential stem cell treatment for several lung conditions

Injectable ART may have same effectiveness as standard oral treatments

Statins prescribed to less than 50% of stroke patients across the US, says study

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News